Related Experiment Video

Updated: Sep 18, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.6K

Improving human papillomavirus vaccination coverage in France: a need to act but not to rush

Nathalie Thilly1,2, Morgane Michel3,4, Sébastien Bruel5,6

  • 1Université de Lorraine, Inserm, INSPIIRE, Nancy, France. nathalie.thilly@univ-lorraine.fr.

Nature Communications
|June 19, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.8K
Titration of Human Coronaviruses Using an Immunoperoxidase Assay12:00

Titration of Human Coronaviruses Using an Immunoperoxidase Assay

Published on: April 28, 2008

38.3K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
520